GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Onward Medical NV (XBRU:ONWD) » Definitions » Common Stock

Onward Medical NV (XBRU:ONWD) Common Stock : €3.62 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Onward Medical NV Common Stock?

Onward Medical NV's quarterly common stock stayed the same from Dec. 2022 (€3.62 Mil) to Jun. 2023 (€3.62 Mil) and stayed the same from Jun. 2023 (€3.62 Mil) to Dec. 2023 (€3.62 Mil).

Onward Medical NV's annual common stock stayed the same from Dec. 2021 (€3.62 Mil) to Dec. 2022 (€3.62 Mil) and stayed the same from Dec. 2022 (€3.62 Mil) to Dec. 2023 (€3.62 Mil).


Onward Medical NV Common Stock Historical Data

The historical data trend for Onward Medical NV's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Onward Medical NV Common Stock Chart

Onward Medical NV Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial - - 3.62 3.62 3.62

Onward Medical NV Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.62 3.62 3.62 3.62 3.62

Onward Medical NV Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Onward Medical NV (XBRU:ONWD) Business Description

Traded in Other Exchanges
Address
High Tech Campus 32, Noord-Braban, Eindhoven, NH, NLD, NL-5656 AE
Onward Medical NV is a medical technology company developing and commercializing therapies to enable functional recovery for people with spinal cord injury. It has developed two programmable neurostimulation platforms: an implantable system, ARCIM, and a non-invasive, transcutaneous system, ARCEX. The company has selected the United states and four European markets: Germany, France, the UK and the Netherlands to create a customer base.

Onward Medical NV (XBRU:ONWD) Headlines

No Headlines